Werbung
Werbung
PASG
Passage Bio, Inc. Common Stock
20.23
USDGesponsert
+1.90
+10.34%
09. Jan., 15:58 UTC -5
Geschlossen
Nach-Markt
20.52
+0.30
+1.48%
PASG Ergebnisberichte
Positives Überraschungsverhältnis
PASG übertreffen die 13 der letzten 23Schätzungen.
57%
Nächster Bericht
Datum des nächsten Berichts
02. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$2.62
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/+7.38%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/-34.50%
Passage Bio, Inc. Common Stock earnings per share and revenue
On 10. Nov. 2025, PASG reported earnings of -2.44 USD per share (EPS) for Q3 25, beating the estimate of -2.85 USD, resulting in a 14.57% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +14.84% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of -2.62 USD, with revenue projected to reach -- USD, implying an increase of 7.38% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
What were Passage Bio, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Passage Bio, Inc. Common Stock reported EPS of -$2.44, beating estimates by 14.57%, and revenue of $0.00, 0% as expectations.
How did the market react to Passage Bio, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 14.84%, changed from $6.71 before the earnings release to $7.70 the day after.
When is Passage Bio, Inc. Common Stock expected to report next?
The next earning report is scheduled for 02. März 2026.
What are the forecasts for Passage Bio, Inc. Common Stock's next earnings report?
Based on 8
analysts, Passage Bio, Inc. Common Stock is expected to report EPS of -$2.62 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung